Biogen Inc (NASDAQ:BIIB) - Overview

Stock Report

Biogen Inc BIIB

Last Price
$297.19

Day Change
1.41|0.48%

As of 02/12/2016
16:00:00 EST | USD
Minimum 15 Minutes Delay.

Last Close295.78
Day Range293.04 - 299.95
Mkt Cap64.66Bil
52-Wk Range223.02 - 333.65
Yield %-
ISINUS09062X1037
Volume1,429,360
P/E16.80
P/S5.72
P/CF16.38

Share Price

Financials
201320142015
More ...
Income Statement
Revenue6,932.209,703.3210,763.80
Operating Income2,515.513,955.664,891.00
Net Income1,862.342,934.783,547.00
Basic EPS7.8612.4215.38
Avg. Diluted Shares Outstanding238237231
Balance Sheet
Current Assets3,184.934,672.676,700.30
Non Current Assets8,678.409,643.8912,804.50
Total Assets11,863.3414,316.5619,504.80
Current Liabilities1,758.282,219.712,577.70
Total Liabilities3,243.093,507.5510,132.00
Total Equity8,620.2410,809.019,372.80
Cash Flow
Operating Cash Flow2,345.082,942.123,716.10
Capital Expenditure-3,509.00-287.75-643.00
Free Cash Flow-1,163.922,654.363,073.10

In millions, except "Basic EPS". Currency is USD.

Company Profile

Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Large-Growth

Fiscal Year Ends

December

Employees

7,350
Key Stats
More ...
Price/Earning TTM16.68
Price/Book5.31
Price/Sales TTM5.87
Rev Growth (3 year avg)24.96
EPS Growth (3 year avg)-
Operating Margin % TTM45.44
Net Margin % TTM32.95
ROE TTM35.15
Debt/Equity0.70
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.